|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.290 SEK | -1.83% |
|
+5.74% | -34.52% |
| 01/07 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| 30/06 | IRLAB Therapeutics Rights Issue Raises About SEK 68 Mln | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.99Cr | - | - | - | ||
| 1,08200Cr | |||||
| 63TCr | |||||
| 46TCr | |||||
| 34TCr | |||||
| 30TCr |
Select your edition
All financial news and data tailored to specific country editions
